BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
-9.09%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.4B
AUM Growth
+$17.4B
Cap. Flow
+$303M
Cap. Flow %
1.74%
Top 10 Hldgs %
85.01%
Holding
123
New
2
Increased
15
Reduced
4
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CBAY
76
DELISTED
Cymabay Therapeutics
CBAY
$6.75M 0.04%
2,170,464
ALT icon
77
Altimmune
ALT
$325M
$6.53M 0.04%
1,072,038
HRMY icon
78
Harmony Biosciences
HRMY
$2.16B
$6.01M 0.03%
123,600
TNGX icon
79
Tango Therapeutics
TNGX
$745M
$5.69M 0.03%
750,000
RVMD icon
80
Revolution Medicines
RVMD
$7.43B
$5.67M 0.03%
222,222
HOOK
81
DELISTED
HOOKIPA Pharma
HOOK
$5.47M 0.03%
2,400,481
+1,700,000
+243% +$3.88M
EWTX icon
82
Edgewise Therapeutics
EWTX
$1.54B
$4.85M 0.03%
500,000
ITOS
83
DELISTED
iTeos Therapeutics
ITOS
$4.84M 0.03%
150,346
ALGS icon
84
Aligos Therapeutics
ALGS
$75.1M
$4.46M 0.03%
2,076,400
NGM
85
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.45M 0.03%
291,801
KURA icon
86
Kura Oncology
KURA
$732M
$4.41M 0.03%
274,458
-29,700
-10% -$478K
BCAB icon
87
BioAtla
BCAB
$28.7M
$4.13M 0.02%
825,000
ALLK
88
DELISTED
Allakos
ALLK
$4.01M 0.02%
703,050
TCRX icon
89
TScan Therapeutics
TCRX
$106M
$3.99M 0.02%
1,425,000
MGNX icon
90
MacroGenics
MGNX
$121M
$3.9M 0.02%
442,579
NVAX icon
91
Novavax
NVAX
$1.2B
$3.55M 0.02%
48,168
ALEC icon
92
Alector
ALEC
$282M
$3.41M 0.02%
239,228
ATYR
93
aTyr Pharma
ATYR
$560M
$3.34M 0.02%
625,000
CYT
94
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$3.06M 0.02%
812,640
DNLI icon
95
Denali Therapeutics
DNLI
$2.24B
$2.86M 0.02%
88,738
KZR icon
96
Kezar Life Sciences
KZR
$28.5M
$2.32M 0.01%
139,676
TCRR
97
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$2.08M 0.01%
753,064
BNR
98
Burning Rock Biotech
BNR
$85.6M
$1.94M 0.01%
209,131
SNDX icon
99
Syndax Pharmaceuticals
SNDX
$1.39B
$1.92M 0.01%
110,729
AKRO icon
100
Akero Therapeutics
AKRO
$3.65B
$1.68M 0.01%
118,378